Governance and Leadership

Strong quality governance is not about hierarchy or documentation volume. It is about accountability, clarity of decision‑making, and the ability to act with confidence when regulatory responsibility rests with the organisation. Governance defines who owns quality decisions, how risks are escalated, and how leadership demonstrates control across the organisation.

In practice, “governance” is where many organisations either build inspection resilience—or unknowingly create structural risk. Regulators and notified bodies rarely fail a company because a template is missing. Findings tend to cluster around unclear accountability, inconsistent decisions, weak oversight of outsourced work, and a quality function that lacks authority or resourcing.

The governance model determines whether your quality system is genuinely in control, or only looks good on paper.

QAlliance’s services related to Governance and Leadership include

QP/RP services
QA resources and consultancy

Here we go deeper into what governance and leadership support looks like in day‑to‑day operations, and when it typically becomes necessary.

When governance becomes the bottleneck

Organisations typically reach out when one or more of these “moments” occur:

Growth or transition
moving from research into regulated development, scaling clinical activity, tech transfer, or expanding to additional regions or sites.

Increased external dependency
more CROs, CDMOs, labs, or platform vendors—without a matching increase in sponsor oversight capability.

Inspection pressure
an upcoming inspection, recurring observations, or concern that internal decisions will not withstand scrutiny.

Quality leadership gap
a senior QA leader leaves, a QP/RP role becomes a single point of failure, or the quality unit is not empowered to make hard calls.

These are governance problems even when they appear as “operational issues”. EU GMP explicitly frames attainment of the quality objective as a senior management responsibility and expects a comprehensively designed, resourced, and monitored pharmaceutical quality system. Similarly, ICH Q10 places “management responsibility” at the centre of an effective pharmaceutical quality system, covering commitment, quality planning, resource management, communication, and management review.

What 'good governance' looks like in a regulated context

Quality governance is the set of decisions and controls that make the organisation predictable, explainable, and defensible under scrutiny. In practical terms, it includes:

Clear accountabilities and decision rights

who owns the system, who approves risk decisions, and what cannot be delegated.
how quality decisions are escalated and documented when timelines or commercial priorities push in the opposite direction.

This aligns with the expectation that the quality unit has defined authority and written procedures, including approval/rejection authority over key quality-impacting elements in the us cGMP model.

Leadership that makes quality operable (not bureaucratic)
A common failure mode is building governance “around” the business instead of into it. Effective leadership integrates quality into operational planning and resourcing, and uses risk-based thinking to focus effort where it matters most—consistent with ICH Q10’s emphasis on state of control and quality planning, and with EU GMP Chapter 1’s emphasis on an adequately resourced PQS.

Oversight models that scale with outsourcing
In modern development and manufacturing, governance must cover outsourced activities with the same seriousness as internal operations. ICH Q10 explicitly addresses management of outsourced activities as part of management responsibility.

How QAlliance typically supports

QP/RP sevices (continuity and regulatory confidence)

We provide experienced qualified person (QP) and responsible person (RP) support in line with eu regulatory requirements, ensuring batch release, regulatory oversight, and ongoing compliance with applicable GxP obligations.

Where this becomes valuable

when the existing QP/RP arrangement creates key-person risk
when you need an independent, senior release decision
when you need stronger linkage between release decisions, deviations, change control, and supplier oversight

QA leadership resourcing (interim, embedded, or advisory)

We offer flexible QA consultancy—from targeted advisory support to embedded QA roles—allowing organisations to scale quality expertise while maintaining continuity, independence, and regulatory alignment.

Typical roles

Interim head of quality / quality director support
Governance set-up during scale-up (boards, committees, escalation routes)
Strengthening quality unit authority and interfaces with operations
Management review and quality performance reporting aligned with leadership expectations described in ICH Q10.

Governance design that links to the quality system

Governance is not separate from the QMS—it is what makes the QMS function. This therefore links tightly to other services we can support you with, such as:

Quality management system design and optimisation
Risk management and quality planning
Change control, deviations, and CAPA effectiveness
Supplier oversight and quality agreements

Examples of problems we help resolve

“We have SOPs, but decisions are inconsistent.”
We map decision rights, define escalation paths, and introduce management review discipline that ties performance, deviations/CAPA, and resourcing decisions together—aligned with ICH Q10 management review principles.

“Our quality unit is not empowered.”
We clarify authority boundaries and ensure written procedures and approval/rejection responsibilities are unambiguous—mirroring the regulatory expectation that the quality unit has defined authority and documented procedures that are followed.

“Outsourcing grew faster than our oversight.”
We design a sponsor/vendor oversight model that matches risk and complexity, and connect it to quality agreements, audit plans, and KPIs—consistent with ICH Q10’s expectations around outsourced activities.

“We need QP continuity without building a full internal organisation yet.”
We provide QP/RP support as part of a broader governance model so release decisions remain integrated with investigations, change control, and supplier quality—not isolated “sign-offs”.

What to expect from us

Expect:

Senior consultants who can make and defend decisions
Pragmatic governance that supports delivery while maintaining control
Documentation that is inspection-credible because it reflects how you actually work

Don’t expect:

Template-heavy systems that look good but don’t survive real pressure
“One size fits all” governance models that ignore your operating reality

If governance and leadership is where you are feeling friction—unclear ownership, stretched QA leadership, or QP/RP continuity risk—this is usually a sign that the organisation is entering a new maturity stage. EU GMP and ICH Q10 both make senior leadership accountability explicit; the practical question is whether your governance model matches that accountability in real operations.

A short, structured conversation is often enough to clarify:

what decisions are currently “floating”
where authority is unclear or ineffective
which governance elements will reduce risk fastest without adding bureaucracy

QAlliance

Governance and Leadership

Contact

Part of CTR Group